ARL8B and breast cancer: Furthermore, the knockdown of Arl8b prevented the enhanced invasiveness of the IR-S human breast cancer cell lines MDA-MB-231, Hs578T, MCF-7 and the mouse mammary tumor cell line 4T1 (Fig. 4h–k).